← back to search

Mad‐Hélénie Elsensohn

Université Claude Bernard Lyon 1 · FR
Area of research
Pathology and Forensic Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Pituitary Gland Disorders and Treatments, SARS-CoV-2 and COVID-19 Research, and COVID-19 and Mental Health.
h-index
11
citations
591
works
25
NIH funding
primary concept
email

Recent publications

Effectiveness of integrated vector management on the incidence of dengue in urban Malaysia: a cluster-randomised controlled trial
The Lancet Infectious Diseases 2025cited by 8position: middledoi
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
Brain Communications 2023cited by 79position: middledoi
Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination
Science Translational Medicine 2023cited by 36position: middledoi
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features
Journal of Neurology Neurosurgery & Psychiatry 2020cited by 100position: middledoi
Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis
Acta Neuropathologica Communications 2020cited by 43position: middledoi
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Journal of Clinical Oncology 2019cited by 248position: middledoi
Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort
Orphanet Journal of Rare Diseases 2016cited by 29position: middledoi
Economic impact of a modification of the treatment trajectories of patients with end-stage renal disease
Nephrology Dialysis Transplantation 2015cited by 35position: middledoi
Comparison of two next-generation sequencing kits for diagnosis of epileptic disorders with a user-friendly tool for displaying gene coverage, DeCovA
Applied & Translational Genomics 2015cited by 28position: middledoi
Modelling treatment trajectories to optimize the organization of renal replacement therapy and public health decision-making
Nephrology Dialysis Transplantation 2013cited by 27position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Claire Bardel · Université Claude Bernard Lyon 13 papers (2015–2020)Pascal Roy · Université Claude Bernard Lyon 13 papers (2015–2020)Emmanuelle Dantony · Université Claude Bernard Lyon 12 papers (2013–2015)Cécile Couchoud · Université Claude Bernard Lyon 12 papers (2013–2015)Alain Calender · Université Claude Bernard Lyon 12 papers (2015–2016)Damien Sanlaville · University of Lausanne2 papers (2015–2020)Emmanuel Villar · Université Claude Bernard Lyon 12 papers (2013–2015)Raphaelle Lamy · Université Claude Bernard Lyon 11 papers (2016–2016) · 1 papers (2025–2025) · 1 papers (2016–2016) · 1 papers (2016–2016) · 1 papers (2015–2015) · 1 papers (2016–2016) · 1 papers (2025–2025) · 1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2025–2025) · 1 papers (2015–2015) · 1 papers (2025–2025) · 1 papers (2025–2025)